Release Date: 28/01/22 14:24 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 278.36KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%